Arkolith/Insider Trading/MACK/Form 4

Crocker Gary L

See Remarks, DirectorMERRIMACK PHARMACEUTICALS INC (MACK) · full profile →Form 4 · filed Apr 1, 2022
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2022Buy(P)300$6.18$2K110K
Mar 30, 2022Buy(P)161$6.20$998110K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-013091) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML